AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read

Trofimuk-O'Connor Christina Alice sold $396K of IBEX

Trofimuk-O'Connor Christina Alice (Chief Legal Officer) sold 9,876 shares of IBEX Ltd (IBEX) at an average of $40.07 ($39.34–$40.30, $0.40M total) across 2 trades over 2026-09-15 to 2026-09-16.

Original reporting
SEC EDGAR · Trofimuk-O'Connor Christina Alice
Published Sep 16, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$IBEX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction represents a modest reduction of insider holdings with no immediate price impact.

02

Market read

Routine insider sale; limited relevance for traders.

03

What to watch

No material impact on share price expected.

Relevance 4/10Novelty 3/10Timing: filed Sep 16 2026

Background

SEC Form 4 filing reporting an insider sale by the Chief Legal Officer of IBEX Ltd.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The sale is small and may not signal insider concern.

Key entities

  • company
    IBEX Ltd

    Issuer of the securities sold.

  • person
    Christina Alice Trofimuk-O'Connor

    Chief Legal Officer and reporting insider.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IBEX insider trading history →

Related articles

SEP 13
$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

yahoo.com2 min
SEP 11
$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

aol.com2 min
SEP 10
$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two

SEC EDGAR 8-K3 min